The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerability, dose intensity, and prescribing patterns of capecitabine by race.
 
Joshua Dower
No Relationships to Disclose
 
Yana Salei
No Relationships to Disclose
 
Benjamin Koethe
No Relationships to Disclose
 
Alex Julian
No Relationships to Disclose
 
Jake Schwartz
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Becton Dickinson; Danaher; Johnson & Johnson; Lilly (I); Procter & Gamble; UnitedHealth
 
Brett Dumas
No Relationships to Disclose
 
Jacob Matt Elkon
No Relationships to Disclose
 
Rachel J. Buchsbaum
Patents, Royalties, Other Intellectual Property - “Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis” Provisional patent application: Docket Number: MITX-9505/00US 317239-2690 5/13/2017 application in collaboration with Dr. Mohammad Movassaghi (Inst)
 
Ilana Schlam
No Relationships to Disclose